Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acute Pain × Passive Cutaneous Anaphylaxis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Pain, Intractable 1 Mucositis 1 Leukemia 1 Inflammatory Bowel Diseases 1 Diverticulitis 1 Diverticular Diseases 1 Colonic Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1 Breast Cancer Female 1 Breakthrough Pain 1 Bone Marrow Failure Disorders 1 Bites and Stings 1 Anemia, Aplastic 1 Agnosia 1 Acute Pain 1

Interventions

Surveys and Questionnaires 3 Ketamine 3 Oxycodone 2 Diclofenac 2 Anesthesia, General 2 Acetaminophen 2 Transcutaneous Electric Nerve Stimulation 1 Ropivacaine 1 Quality of Life 1 Psychotherapy 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Minocycline 1 Meloxicam 1 Ketorolac Tromethamine 1 Ketorolac 1 Ibuprofen 1 Hydromorphone 1 Gabapentin 1 Fentanyl 1 Ethyl Chloride 1 Duloxetine Hydrochloride 1 Diathermy 1 Cryotherapy 1 Control Groups 1 Anti-Inflammatory Agents, Non-Steroidal 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡